These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1005 related articles for article (PubMed ID: 28811340)

  • 1. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection
    Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model for studying viscerotropic disease caused by yellow fever virus infection.
    Meier KC; Gardner CL; Khoretonenko MV; Klimstra WB; Ryman KD
    PLoS Pathog; 2009 Oct; 5(10):e1000614. PubMed ID: 19816561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.
    Fernandez-Garcia MD; Meertens L; Chazal M; Hafirassou ML; Dejarnac O; Zamborlini A; Despres P; Sauvonnet N; Arenzana-Seisdedos F; Jouvenet N; Amara A
    mBio; 2016 Feb; 7(1):e01956-15. PubMed ID: 26861019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
    Jiang X; Dalebout TJ; Lukashevich IS; Bredenbeek PJ; Franco D
    J Gen Virol; 2015 Apr; 96(Pt 4):804-814. PubMed ID: 25516543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex.
    Davis EH; Beck AS; Strother AE; Thompson JK; Widen SG; Higgs S; Wood TG; Barrett ADT
    mBio; 2019 Oct; 10(5):. PubMed ID: 31641088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.
    Ma J; Boudewijns R; Sanchez-Felipe L; Mishra N; Vercruysse T; Buh Kum D; Thibaut HJ; Neyts J; Dallmeier K
    Emerg Microbes Infect; 2021 Dec; 10(1):2279-2290. PubMed ID: 34792431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism.
    Wang HJ; Guo Y; He MJ; Liu ZY; Ye Q; Huang XY; Deng YQ; Li XF; Qin CF
    Microbiol Spectr; 2022 Oct; 10(5):e0224622. PubMed ID: 35980184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model.
    Engelmann F; Josset L; Girke T; Park B; Barron A; Dewane J; Hammarlund E; Lewis A; Axthelm MK; Slifka MK; Messaoudi I
    PLoS Negl Trop Dis; 2014; 8(11):e3295. PubMed ID: 25412185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.
    Calvert AE; Dixon KL; Piper J; Bennett SL; Thibodeaux BA; Barrett AD; Roehrig JT; Blair CD
    Antiviral Res; 2016 Jul; 131():92-9. PubMed ID: 27126613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination.
    Sandberg JT; Ols S; Löfling M; Varnaitė R; Lindgren G; Nilsson O; Rombo L; Kalén M; Loré K; Blom K; Ljunggren HG
    J Immunol; 2021 Aug; 207(4):1033-1043. PubMed ID: 34321231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells.
    Cong Y; McArthur MA; Cohen M; Jahrling PB; Janosko KB; Josleyn N; Kang K; Zhang T; Holbrook MR
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004709. PubMed ID: 27191161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-interferon exerts a critical early restriction on replication and dissemination of yellow fever virus vaccine strain 17D-204.
    Lam LKM; Watson AM; Ryman KD; Klimstra WB
    NPJ Vaccines; 2018; 3():5. PubMed ID: 29387474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Infections of Zika, Dengue, and Yellow Fever Viruses in Human Cytotrophoblast-Derived Cells Suggest a Gating Role for the Cytotrophoblast in Zika Virus Placental Invasion.
    Viettri M; Caraballo G; Sanchez ME; Espejel-Nuñez A; Betanzos A; Ortiz-Navarrete V; Estrada-Gutierrez G; Nava P; Ludert JE
    Microbiol Spectr; 2023 Jun; 11(3):e0063023. PubMed ID: 37227282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evidence for the immunogenicity and immune persistence of vaccination with yellow fever virus strain 17D in Chinese peacekeepers deployed to Africa.
    Jia Q; Jia C; Liu Y; Yang Y; Qi J; Tong L; Chen H; Zhang M; Che J; Li B; Li Z
    Antiviral Res; 2019 Feb; 162():1-4. PubMed ID: 30529359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host.
    Mandl JN; Akondy R; Lawson B; Kozyr N; Staprans SI; Ahmed R; Feinberg MB
    J Immunol; 2011 Jun; 186(11):6406-16. PubMed ID: 21515797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice.
    Tretyakova I; Nickols B; Hidajat R; Jokinen J; Lukashevich IS; Pushko P
    Virology; 2014 Nov; 468-470():28-35. PubMed ID: 25129436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The early cellular signatures of protective immunity induced by live viral vaccination.
    Kohler S; Bethke N; Böthe M; Sommerick S; Frentsch M; Romagnani C; Niedrig M; Thiel A
    Eur J Immunol; 2012 Sep; 42(9):2363-73. PubMed ID: 22733156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
    Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.
    Kum DB; Boudewijns R; Ma J; Mishra N; Schols D; Neyts J; Dallmeier K
    Emerg Microbes Infect; 2020; 9(1):520-533. PubMed ID: 32116148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain.
    Thibodeaux BA; Garbino NC; Liss NM; Piper J; Blair CD; Roehrig JT
    Vaccine; 2012 May; 30(21):3180-7. PubMed ID: 22425792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.